Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
DanielleL. Rosnov, MichaelC. Roberts, EmilyD. Kessler, Jennifer
Shroff Pendley, George Datto & Sandra Hassink. (2011) Acceptability of Weight-Loss Interventions Among Adolescents Who Are Overweight and Their Caregivers. Children's Health Care 40:3, pages 179-196.
Read now
Read now
France Nguyen. (2007) Gauging the Acceptability of HIV Vaccines: An Exploratory Study Examining Knowledge, Attitudes, and Beliefs Among Injecting Drug Users in Viet Nam. Journal of Ethnic & Cultural Diversity in Social Work 16:1-2, pages 161-192.
Read now
Read now
F. Starace, T. M. Wagner, A. M. Luzi, L. Cafaro, P. Gallo & G. Rezza. (2006) Knowledge and attitudes regarding preventative HIV vaccine clinical trials in Italy: Results of a national survey. AIDS Care 18:1, pages 66-72.
Read now
Read now
L. Sherr, G. Bolding & J. Elford. (2004) Recruiting London gay men into an HIV vaccine trial: Is it feasible?. AIDS Care 16:5, pages 565-571.
Read now
Read now
Articles from other publishers (26)
Ahmad Farid Nazmi Abdul Halim, Dzulfitree Ahmad, Jane Ling Miaw Yn, Noor Azreen Masdor, Nurfatehar Ramly, Rahayu Othman, Thinakaran Kandayah, Mohd Rohaizat Hassan & Rahmat Dapari. (2022) Factors Associated with the Acceptability of Mass Drug Administration for Filariasis: A Systematic Review. International Journal of Environmental Research and Public Health 19:19, pages 12971.
Crossref
Crossref
Reza A. Niles, Charles R. Thickstun, Horace Cox, Daniel Dilliott, Clara R. Burgert-Brucker, Emma M. Harding-Esch, Nikita Clementson, Annastacia Sampson, Jean Seme Alexandre, Ana C. Morice Trejos, Ronaldo G. Carvalho Scholte & Alison Krentel. (2021) Assessing factors influencing communities’ acceptability of mass drug administration for the elimination of lymphatic filariasis in Guyana. PLOS Neglected Tropical Diseases 15:9, pages e0009596.
Crossref
Crossref
S. Marie Harvey, Susannah E. Gibbs & Aleksandra E. Sikora. (2021) A Critical Need for Research on Gonorrhea Vaccine Acceptability. Sexually Transmitted Diseases 48:8, pages e116-e118.
Crossref
Crossref
Alison Krentel, Nandha Basker, Madsen Beau de Rochars, Joshua Bogus, Daniel Dilliott, Abdel N. Direny, Christine Dubray, Peter U. Fischer, Adriani Lomi Ga, Charles W. Goss, Myra Hardy, Cade Howard, Purushothaman Jambulingam, Christopher L. King, Moses Laman, Jean Frantz Lemoine, Shruti Mallya, Leanne J. Robinson, Josaia Samuela, Ken B. Schechtman, Andrew C. Steer, Taniawati Supali, Livingstone Tavul & Gary J. Weil. (2021) A multicenter, community-based, mixed methods assessment of the acceptability of a triple drug regimen for elimination of lymphatic filariasis. PLOS Neglected Tropical Diseases 15:3, pages e0009002.
Crossref
Crossref
Jennifer L. Brown, Jessica M. Sales & Ralph J. DiClemente. (2014) Combination HIV Prevention Interventions: The Potential of Integrated Behavioral and Biomedical Approaches. Current HIV/AIDS Reports 11:4, pages 363-375.
Crossref
Crossref
Yuan Dong, Xiaoxing Shen, Ruizhang Guo, Baochi Liu, Lingyan Zhu, Jing Wang, Linxia Zhang, Jun Sun, Xiaoyan Zhang & Jianqing Xu. (2014) Willingness to Participate in HIV Therapeutic Vaccine Trials among HIV-Infected Patients on ART in China. PLoS ONE 9:11, pages e111321.
Crossref
Crossref
Michael P. Cameron, Peter A. Newman, Surachet Roungprakhon & Riccardo Scarpa. (2013) The marginal willingness-to-pay for attributes of a hypothetical HIV vaccine. Vaccine 31:36, pages 3712-3717.
Crossref
Crossref
Julia Painter, Clare Cene-Kush, Alaina Conner, Carrie Cwiak, Lisa Haddad, Mark Mulligan & Ralph DiClemente. (2013) Anticipated HIV Vaccine Acceptability among Sexually Active African-American Adult Women. Vaccines 1:2, pages 88-104.
Crossref
Crossref
J T GaleaJ J KinslerX SalazarS-J LeeM GironJ N SaylesC CáceresW E Cunningham. (2011) Acceptability of pre-exposure prophylaxis as an HIV prevention strategy: barriers and facilitators to pre-exposure prophylaxis uptake among at-risk Peruvian populations. International Journal of STD & AIDS 22:5, pages 256-262.
Crossref
Crossref
Peter A Newman & Carmen Logie. (2010) HIV vaccine acceptability: a systematic review and meta-analysis. AIDS 24:11, pages 1749-1756.
Crossref
Crossref
Peter A. Newman, Surachet Roungprakhon, Suchon Tepjan & Suzy Yim. (2010) Preventive HIV vaccine acceptability and behavioral risk compensation among high-risk men who have sex with men and transgenders in Thailand. Vaccine 28:4, pages 958-964.
Crossref
Crossref
S. Gurunathan, R. El Habib, L. Baglyos, C. Meric, S. Plotkin, B. Dodet, L. Corey & J. Tartaglia. (2009) Use of predictive markers of HIV disease progression in vaccine trials. Vaccine 27:14, pages 1997-2015.
Crossref
Crossref
Lora L. Black, Gregory D. Zimet, Mary B. Short, Lynne Sturm & Susan L. Rosenthal. (2009) Literature review of human papillomavirus vaccine acceptability among women over 26 years. Vaccine 27:11, pages 1668-1673.
Crossref
Crossref
Loida E. Bonney, Jennifer S. Rose, Jennifer G. Clarke, Megan R. Hebert, Cynthia Rosengard & Michael Stein. (2007) Correlates of Acceptance of a Hypothetical Gonorrhea Vaccine by Incarcerated Women. Sexually Transmitted Diseases 34:10, pages 778-782.
Crossref
Crossref
Bill G Kapogiannis & Sonia S Lee. (2007) Rolling up our sleeves now to reap the benefits later: preparing the community for an adolescent HIV vaccine. Current Opinion in HIV and AIDS 2:5, pages 375-384.
Crossref
Crossref
Scott D. Rhodes & Leland J. Yee. (2007) Using hepatitis A and B vaccination as a paradigm for effective HIV vaccine delivery. Sexual Health 4:2, pages 121.
Crossref
Crossref
Michelle Lally, Melissa Gaitanis, Snigdha Vallabhaneni, Steven Reinert, Kenneth Mayer, Gregory Zimet & Josiah Rich. (2006) Willingness to receive an HIV vaccine among incarcerated persons. Preventive Medicine 43:5, pages 402-405.
Crossref
Crossref
Peter A. Newman, Naihua Duan, Sung-Jae Lee, Ellen T. Rudy, Danielle S. Seiden, Lisa Kakinami & William E. Cunningham. (2006) HIV vaccine acceptability among communities at risk: The impact of vaccine characteristics. Vaccine 24:12, pages 2094-2101.
Crossref
Crossref
Paul Ritvo, Kumanan Wilson, Dennis Willms & Ross Upshur. (2005) Vaccines in the public eye. Nature Medicine 11:S4, pages S20-S24.
Crossref
Crossref
Peter A. NewmanNaihua DuanEllen T. RudyPeter A. Anton. (2004) Challenges for HIV Vaccine Dissemination and Clinical Trial Recruitment: If We Build It, Will They Come?. AIDS Patient Care and STDs 18:12, pages 691-701.
Crossref
Crossref
Peter A Newman, Naihua Duan, Ellen T Rudy, Kathleen J Roberts & Dallas Swendeman. (2004) Posttrial HIV Vaccine Adoption: Concerns, Motivators, and Intentions Among Persons at Risk For HIV. JAIDS Journal of Acquired Immune Deficiency Syndromes 37:3, pages 1393-1403.
Crossref
Crossref
Rose M. Mays & Gregory D. Zimet. (2004) Recommending STI Vaccination to Parents of Adolescents: The Attitudes of Nurse Practitioners. Sexually Transmitted Diseases 31:7, pages 428-432.
Crossref
Crossref
C.J Clements, Q Abdool-Karim, M.-L Chang, B Nkowane & J Esparza. (2004) Breaking new ground—are changes in immunization services needed for the introduction of future HIV/AIDS vaccines and other new vaccines targeted at adolescents?. Vaccine 22:21-22, pages 2822-2826.
Crossref
Crossref
Peter A Newman, Naihua Duan, Ellen T Rudy & Kathleen Johnston-Roberts. (2004) HIV risk and prevention in a post-vaccine context. Vaccine 22:15-16, pages 1954-1963.
Crossref
Crossref
&NA;. (2003) Public health considerations for the use of a first generation HIV vaccine Report from a WHO-UNAIDS-CDC Consultation, Geneva, 20–21 November 2002. AIDS 17:15, pages W1-W10.
Crossref
Crossref
P.H Streefland. (2003) Introduction of a HIV vaccine in developing countries: social and cultural dimensions. Vaccine 21:13-14, pages 1304-1309.
Crossref
Crossref